Article Information
History
- August 13, 2020.
Article Versions
- Version 1 (April 22, 2020 - 21:15).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- David RM Smith*,1,2,3,†,
- Audrey Duval*,1,
- Koen B Pouwels4,5,
- Didier Guillemot1,2,6,
- Jérôme Fernandes7,
- Bich-Tram Huynh1,
- Laura Temime§,3,8 and
- Lulla Opatowski§,1,2
- on behalf of the AP-HP/Universities/Inserm COVID-19 research collaboration
- 1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
- 2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
- 3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
- 4Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- 5The National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
- 6AP-HP, Paris Saclay, Public Health, Medical Information, Clinical Research, Le Kremlin-Bicêtre, France
- 7Clinique de soins de suite et réadaptation, Choisy-Le-Roi, France
- 8PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
- ↵*Corresponding author: David R. M. Smith (david.smith{at}pasteur.fr), 25 rue du Dr Roux Paris 75015 France
↵* contributed equally
§ contributed equally